Annual Cash & Cash Equivalents
$16.43 M
+$594.00 K+3.75%
December 31, 2022
Summary
- As of February 10, 2025, STSA annual cash & cash equivalents is $16.43 million, with the most recent change of +$594.00 thousand (+3.75%) on December 31, 2022.
- During the last 3 years, STSA annual cash & cash equivalents has fallen by -$6.33 million (-27.80%).
Performance
STSA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$19.53 M
+$3.10 M+18.85%
March 31, 2023
Summary
- As of February 10, 2025, STSA quarterly cash and cash equivalents is $19.53 million, with the most recent change of +$3.10 million (+18.85%) on March 31, 2023.
- Over the past year, STSA quarterly cash and cash equivalents has dropped by -$1.83 million (-8.58%).
Performance
STSA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
STSA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.8% | -8.6% |
| 3 y3 years | -27.8% | -14.7% |
| 5 y5 years | +890.9% | - |
STSA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -3.6% | -51.9% | -18.9% |
| 5 y | 5-year | -54.8% | -3.6% | -80.9% | -18.9% |
| alltime | all time | -54.8% | -89.9% | -80.9% | -73.3% |
Satsuma Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $19.53 M(+18.9%) |
| Dec 2022 | $16.43 M(+3.8%) | $16.43 M(-59.5%) |
| Sep 2022 | - | $40.56 M(+70.7%) |
| Jun 2022 | - | $23.76 M(+11.3%) |
| Mar 2022 | - | $21.36 M(+34.9%) |
| Dec 2021 | $15.84 M(-56.4%) | $15.84 M(-62.5%) |
| Sep 2021 | - | $42.26 M(-21.5%) |
| Jun 2021 | - | $53.86 M(-47.3%) |
| Mar 2021 | - | $102.22 M(+181.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $36.33 M(+59.6%) | $36.33 M(-12.5%) |
| Sep 2020 | - | $41.52 M(+29.2%) |
| Jun 2020 | - | $32.13 M(+40.3%) |
| Mar 2020 | - | $22.90 M(+0.7%) |
| Dec 2019 | $22.75 M(+337.2%) | $22.75 M(-70.7%) |
| Sep 2019 | - | $77.66 M(+63.1%) |
| Jun 2019 | - | $47.62 M(+814.9%) |
| Dec 2018 | $5.21 M(+213.9%) | $5.21 M |
| Dec 2017 | $1.66 M | - |
FAQ
- What is Satsuma Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Satsuma Pharmaceuticals?
- What is Satsuma Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Satsuma Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Satsuma Pharmaceuticals?
- What is Satsuma Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Satsuma Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of STSA is $16.43 M
What is the all time high annual cash & cash equivalents for Satsuma Pharmaceuticals?
Satsuma Pharmaceuticals all-time high annual cash & cash equivalents is $36.33 M
What is Satsuma Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, STSA annual cash & cash equivalents has changed by +$594.00 K (+3.75%)
What is Satsuma Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of STSA is $19.53 M
What is the all time high quarterly cash and cash equivalents for Satsuma Pharmaceuticals?
Satsuma Pharmaceuticals all-time high quarterly cash and cash equivalents is $102.22 M
What is Satsuma Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, STSA quarterly cash and cash equivalents has changed by -$1.83 M (-8.58%)